Sanofi Aktie

46,20 EUR +0,20 EUR +0,43 %

28.04.2025

STU

52,78 USD +0,45 USD +0,85 %

28.04.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV20,07Div. Rendite3,34%

WKN662283

ISINUS80105N1054

SymbolSNY

Sanofi Aktien News

Sortieren:Datum Meistgelesen

24.04.25BenzingaFrench Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

24.04.25ZacksSanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth

24.04.25GlobeNewswirePress Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

WerbungSanofi-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

23.04.25ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

21.04.25ZacksSanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

18.04.25GlobeNewswirePress Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

16.04.25ZacksSanofi Advances Mid-to-Late-Stage Pipeline in Respiratory Indications

15.04.25BenzingaSanofi Asthma Drug Misses Primary Goal, Plans For Pivotal Study

15.04.25PR NewswireChrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

15.04.25GlobeNewswirePress Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD

11.04.25ZacksWhy You Shouldn't Bet Against Sanofi (SNY) Stock

08.04.25GlobeNewswirePress Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

03.04.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - February 2025

03.04.25BenzingaWhy Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?

03.04.25BenzingaLamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday

03.04.25GlobeNewswirePress Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

28.03.25GlobeNewswirePress Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

28.03.25GlobeNewswirePress Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

26.03.25GlobeNewswirePress Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

25.03.25GlobeNewswirePress Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

24.03.25GlobeNewswirePress Release: Availability of the Q1 2025 Aide mémoire

20.03.25ZacksSanofi Inks $1.9B Deal With Dren Bio to Buy Autoimmune Disease Drug

20.03.25BenzingaSanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal

20.03.25GlobeNewswirePress Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

14.03.25PR NewswireSanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

12.03.25BenzingaSanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?

08.03.25GlobeNewswirePress Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

05.03.25GlobeNewswirePress release: Sanofi successfully prices EUR 1.5 billion of bond issue

25.02.25GlobeNewswirePress Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

24.02.25ZacksThe Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis

22.02.25GlobeNewswirePress Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

19.02.25GlobeNewswirePress Release: Sanofi and CD&R sign Opella share purchase agreement

18.02.25GlobeNewswirePress Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid

13.02.25GlobeNewswirePress Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

13.02.25GlobeNewswirePress Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

07.02.25GlobeNewswirePress Release: Execution of a share buyback agreement for up to €2 billion

03.02.25BenzingaSanofi Buys Back ~$3 Billion In Shares From L'Oréal: Details

03.02.25GlobeNewswirePress Release: Sanofi announces buy back of shares from L’Oréal

31.01.25GlobeNewswirePress Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

30.01.25MotleyFoolSanofi (SNY) Q4 2024 Earnings Call Transcript

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.